Anyone here using Agilent SS All Exon V7 kit? I'm continuously getting low yield around 2-3 nM with 100ng input. Any suggestions?
-
-
Which library and capture kit are you using? I tested the Exon V7 probes with SureSelectXT and SureSelectXT HS a while back. XT gave >50 nM while XT HS gave around 10 nM. Started with 200 ng as the starting concentration. -
Hey thanks! I am using SS XT Low Input kit with dual index. While I did the test run I got really good yield (around 10-12nM) with 100ng input. I am starting to think it could be reagent issueComment
-
SS XT Low Input has a similar workflow to HS. After library prep, 1000 ng was inputted into hybridization. Other places where I see can affect yield is lost of the capture beads during the washing step.
Are these the same samples as your test run? They could be DNA of poorer quality.Comment
-
Thanks a lot for your reply. Have you done the SS All Exon V7 dual index library or with MBC? Because the yield with the MBC is ranging from 4-10 nM and for the dual index libraries it goes down to half (1-3nM).Surprisingly, they are consistent throughout the samples. We are working with the Agilent tech support on site and we haven't figured out the explanation yet!!Comment
-
It was with the MBC. You could increase the post-capture PCR cycle by 1 but you might see higher PCR duplicate reads during analysis. I'm curious to see if there are any differences in the sample metrics (% on-target, % duplicates, etc.) and variant calling between the MBC and dual index.Comment
-
Did you get your answer from Agilent Tech Support so far? I am experiencing the same issue using the SureSelect HS with dual-index.Originally posted by baru View Post
CheersComment
-
Hello! I'm sorry I missed your query. Well, I did a couple of optimization like increasing the bead capture to 1 hr and reducing the elution volume to 20 ul. Yield slightly improved. So we sequenced them anyway on an SP flow cell before moving with our larger sets of samples. Exome quality was extremely good in the end. So don't worry about the yield, as long your libraries are of good quality go ahead and sequence them
ps: This is just my experienceComment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment